China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina said at the time that it was working to find a solution. “We respect and abide by Chinese laws and regulations,” the ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Illumina aims to transform human health practices through its leadership of genomic sequencing and related applications. The firm provides a broad range of instruments and related consumables to ...

Illumina is a prominent entity in the genomic sequencing market, providing advanced DNA sequencing platforms and associated products. Its technologies are vital across research, clinical ...

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

"Spatially registering the single-molecule imaging and Illumina sequencing data turned out ... along with the ease of ...